Exploring the Impact of Infusion Frequency in Hemophilia A: Exit Interviews with Patients Participating in BAY 94-9027 Extension Studies (PROTECT VIII)

por Wells, Jane R., Gater, Adam, Marshall, Chris, Tritton, Theo, Vashi, Parth, Kessabi, Sophia
Publicado no Patient (2019)

Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with sever...

por Batt, Katharine, Gao, Wei, Ayyagari, Rajeev, Deschaseaux, Céline, Vashi, Parth B, Yao, Zhiwen, Wang, Yao, Kessabi, Sophia, Klamroth, Robert
Publicado no J Blood Med (2019)